Altamira Therapeutics to Report Bentrio Clinical Data, in Ho

Altamira Therapeutics to Report Bentrio Clinical Data, in House Dust Mite and Grass Pollen Allergic Rhinitis, at Feb. 25 AAAAI Annual Meet-ing

Altamira Therapeutics to Report Bentrio Clinical Data, in House Dust Mite and Grass Pollen Allergic Rhinitis, at Feb. 25 AAAAI Annual Meet-ing

pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Tubingen , Baden Wüberg , Germany , United States , San Antonio , Texas , Canada , Switzerland , Bermuda , American , Anne Marie Salapatek , Securities Exchange Commission , Company Bentrio , Fraunhofer Institute For Toxicology , Nasdaq , Cliantha Research , University Of Tubingen , Altamira Therapeutics Ltd , Securities Exchange , Meeting Of The American Academy Allergy , Altamira Therapeutics , Annual Meeting , American Academy , Barrier Forming Drug Free Nasal Spray , Allergic Rhinitis Patients Exposed , Controlled Grass Pollen , House Dust Mite , Total Nasal Symptom Score , Fraunhofer Institute , Experimental Medicine , Securities Act , Securities Exchange Act , Altamira Therapeutic , Risk Factor , Altamira Therapeutic Annual Report ,